Vergote I - Search Results

1

Laparoscopic lower para-aortic staging lymphadenectomy in stage IB2, II, and III cervical cancer.

Vergote I, Amant F, Berteloot P, Van Gramberen M. Vergote I, et al. Int J Gynecol Cancer. 2002 Jan-Feb;12(1):22-6. doi: 10.1046/j.1525-1438.2002.01070.x. Int J Gynecol Cancer. 2002. PMID: 11860532

2

Intraperitoneal contrast material combined with CT for detection of peritoneal metastases of ovarian cancer.

Gryspeerdt S, Clabout L, Van Hoe L, Berteloot P, Vergote IB. Gryspeerdt S, et al. Among authors: vergote ib. Eur J Gynaecol Oncol. 1998;19(5):434-7. Eur J Gynaecol Oncol. 1998. PMID: 9863905 Clinical Trial.

3

Incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.

Vergote I, De Smet I, Amant F. Vergote I, et al. Gynecol Oncol. 2002 Mar;84(3):537-8. doi: 10.1006/gyno.2001.6422. Gynecol Oncol. 2002. PMID: 11855893 No abstract available.

4

PTEN mutation analysis in uterine leiomyosarcomas and mixed mullerian sarcomas.

Amant F, Vergote I. Amant F, et al. Among authors: vergote i. Am J Obstet Gynecol. 2002 Jul;187(1):258. doi: 10.1067/mob.2002.124942. Am J Obstet Gynecol. 2002. PMID: 12114928 No abstract available.

5

The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis.

Luo LY, Katsaros D, Scorilas A, Fracchioli S, Bellino R, van Gramberen M, de Bruijn H, Henrik A, Stenman UH, Massobrio M, van der Zee AG, Vergote I, Diamandis EP. Luo LY, et al. Among authors: vergote i. Cancer Res. 2003 Feb 15;63(4):807-11. Cancer Res. 2003. PMID: 12591730

6

Ethnic variations in uterine leiomyoma biology are not caused by differences in myometrial estrogen receptor alpha levels.

Amant F, Huys E, Geurts-Moespot A, Lindeque BG, Vergote I, Sweep F, Schoenmakers EF. Amant F, et al. Among authors: vergote i. J Soc Gynecol Investig. 2003 Feb;10(2):105-9. doi: 10.1016/s1071-5576(02)00253-8. J Soc Gynecol Investig. 2003. PMID: 12594000

7

Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma.

Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Katsaros D. Diamandis EP, et al. Among authors: vergote i. J Clin Oncol. 2003 Mar 15;21(6):1035-43. doi: 10.1200/JCO.2003.02.022. J Clin Oncol. 2003. PMID: 12637468

8

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

D'Agostino G, Amant F, Berteloot P, Scambia G, Vergote I. D'Agostino G, et al. Among authors: vergote i. Gynecol Oncol. 2003 Mar;88(3):266-9. doi: 10.1016/s0090-8258(03)00011-8. Gynecol Oncol. 2003. PMID: 12648573 Clinical Trial.

9

Endometrial stromal sarcoma with a sole t(X;17) chromosome change: report of a case and review of the literature.

Amant F, Moerman P, Cadron I, Hagemeijer A, Vergote I, Debiec-Rychter M. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2003 Mar;88(3):459-62. doi: 10.1016/s0090-8258(02)00096-3. Gynecol Oncol. 2003. PMID: 12648605 Review.

10

Immunohistochemical determination of hormone receptors in uterine adenosarcomas.

Amant F, Gabriel C, Moerman P, Vergote I. Amant F, et al. Among authors: vergote i. Gynecol Oncol. 2003 Mar;88(3):463-4. doi: 10.1016/s0090-8258(02)00006-9. Gynecol Oncol. 2003. PMID: 12648606 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

888 results

Search Page

Filters